GlassScriptPhysician profile
Karin A Myers
NPI 1134213853
$2,438.64
in general payments reported to CMS, 2019-2025
17 companies · $578 in 2025
The $578 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $523 · 2022: $353 · 2023: $597 · 2024: $388 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,377 · Education: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,376.92 |
| Education | $186.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $507.18 | 2021-2025 | |
| Genzyme Corporation | $347.96 | 2021-2025 | |
| Leo Pharma INC. | $330.42 | 2021-2025 | Adbry, Anzupgo |
| Janssen Biotech, INC. | $312.39 | 2021-2025 | Tremfya, Simponi, Stelara |
| E.R. Squibb & Sons, L.L.C. | $249.51 | 2023-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $141.25 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $135.11 | 2021-2025 | Libtayo |
| Galderma Laboratories, L.P. | $76.11 | 2021-2025 | Nemluvio |
| Sanofi-Aventis U.S. LLC | $72.00 | 2024 | |
| Incyte Corporation | $57.04 | 2023-2024 | Opzelura |
| Genentech USA, INC. | $48.36 | 2021 | |
| Pfizer INC. | $44.73 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.55 | 2021 | |
| Ucb, INC. | $30.05 | 2021 | |
| Lilly USA, LLC | $21.98 | 2023 | Olumiant |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $17.88 | 2023 | |
| Mayne Pharma Commercial LLC | $13.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karin Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.